封面
市場調查報告書
商品編碼
2077357

全球及中國導尿管市場:依產品類型、最終用戶及地區分類

Global And China Catheter Market, By Product Type, By End User, and By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球及中國導管市場預計到 2026 年將達到 544.4 億美元,到 2033 年將達到 781.5 億美元。從 2026 年到 2033 年,預計年複合成長率為 5.3%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 544.4億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 5.30% 2033年市場規模預測: 781.5億美元

隨著越來越多的公司致力於研發先進導管,導管市場競爭日益激烈。許多製造商與大型醫療設備經銷商合作,在全球範圍內或特定國家/地區銷售和供應其產品。許多老字型大小企業也正採用各種有機和無機成長策略來擴大市場佔有率。此外,新產品發布、併購和合作也是這些公司確保永續成長的關鍵策略。市場的主要參與者包括貝朗醫療(B. Braun Melsungen AG)、康樂保(Coloplast)、康維特集團(ConvaTec Group)、霍利斯特公司(Hollister Incorporated)、美敦力公司(Medtronic PLC)、泰利福(Teleflex)和波士頓科學公司(Boston Scientific Corporation)。

市場動態

預計主要市場參與企業將擴大採用非內生性成長策略(例如業務擴張)將推動全球對導管的需求。例如,2023年6月8日,醫療技術製造商和分銷商Merit Medical Systems, Inc.宣布完成對AngioDynamics, Inc.的透析導管產品組合和BioSentry切片檢查通道密封系統的收購,總交易額為1000億美元現金。 Merit近期也宣布以325億美元現金從Bluegrass Vascular Technologies, Inc.收購Surfacer Inside-Out Access Catheter System。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數,對全球和中國導管市場的主要公司進行了概況介紹:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球及中國導管市場報告》旨在為產業內的各種相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種策略矩陣來分析全球和中國導管市場,從而促進決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • PEST分析

第4章 全球導管市場:依產品類型分類,2021-2033年

  • 心血管導管
  • 泌尿系統
  • 靜脈導管
  • 神經血管導管
  • 特殊導管

第5章 全球導管市場:依最終用戶分類,2021-2033年

  • 醫院
  • 門診手術中心
  • 專科診所

第6章 全球導管市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非
    • 其他非洲地區

第7章:公司簡介

  • Cordis(Cardinal Health)
  • Abbott Laboratories
  • B. BRAUN
  • Medtronic plc
  • Terumo
  • Teleflex Corporation
  • CR Bard, Inc.
  • RIST Neurovascular, Inc.
  • Edwards Lifesciences
  • Cook Medical Incorporated
  • Merit Medical
  • Biotronik
  • BALT
  • Osypka AG
  • Japan Lifeline
  • ACT
  • Lepu
  • Microport
  • SCW Medicath
  • Boston Scientific Corporation
  • Coloplast A/S
  • Convatec Group PLC
  • Dentsply
  • Bactiguard
  • Hollister Incorporated
  • Pacific Hospital Supply Co. Ltd.
  • Rochester Medical Corporation
  • Fuqing Medical
  • Medsuyun
  • Songhang
  • Sanli
  • Chensheng Medical
  • Haiou Medical
  • CATHETRIX
  • World Medical

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4010

Global And China Catheter Market is estimated to be valued at USD 54.44 Bn in 2026 and is expected to reach USD 78.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 54.44 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.30% 2033 Value Projection: USD 78.15 Bn

The catheters market is highly competitive as there have been a wide number of companies that have increased its focus on developing advanced catheters. Numerous manufacturers have collaborated with major medical device distributors to market and supply its products globally or in certain countries. Various established business players are also adopting numerous organic and inorganic growth strategies to increase their market shares. Also, product launches, mergers and acquisitions, and collaborations are the key strategies undertaken by these companies for sustainable growth. Some of the major players in this market include B. Braun Melsungen AG, Coloplast, ConvaTec Group, Hollister Incorporated, Medtronic PLC, Teleflex, and Boston Scientific Corporation, among others.

Market Dynamics

Increasing adoption of inorganic strategy such as expansion by key market players is expected to increase the demand for global and catheter market. For Instance, on june 08, 2023, Merit Medical Systems, Inc., a manufacturer and marketer of healthcare technology, announced it has completed the acquisition of a portfolio of dialysis catheter products and the BioSentry Biopsy Tract Sealant System from AngioDynamics, Inc. for a total cash consideration of US$100 Billion. Merit also announced the recent acquisition of the Surfacer Inside-Out Access Catheter System from Bluegrass Vascular Technologies, Inc. for a total cash consideration of $32.5 Billion.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global and china catheter market based on the following parameters- Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Cordis (Cardinal Health), Abbott Laboratories, B. BRAUN, Medtronic plc, Terumo, Teleflex Corporation, C. R. Bard, Inc., RIST Neurovascular, Inc., Edwards Lifesciences, Cook Medical Incorporated, Merit Medical, Biotronik, BALT, Osypka AG, Japan Lifeline, ACT, Lepu, Microport, SCW Medicath, Boston Scientific Corporation, Coloplast A/S, Convatec Group PLC, Dentsply, Bactiguard, Hollister Incorporated, Pacific Hospital Supply Co. Ltd., Rochester Medical Corporation, Fuqing Medical, Medsuyun, Songhang, Sanli, Chensheng Medical, Haiou Medical, CATHETRIX, and World Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global and china catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global and china catheter market

Detailed Segmentation:

  • Global And China Catheter Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Cardiovascular catheter
  • Urology Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Specialty Catheters
  • Global And China Catheter Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Global And China Catheter Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Cordis (Cardinal Health)
  • Abbott Laboratories
  • BRAUN, Medtronic plc
  • Terumo, Teleflex Corporation
  • R. Bard, Inc.
  • RIST Neurovascular, Inc.
  • Edwards Lifesciences
  • Cook Medical Incorporated
  • Merit Medical
  • Biotronik
  • BALT
  • Osypka AG
  • Japan Lifeline
  • ACT
  • Lepu
  • Microport
  • SCW Medicath
  • Boston Scientific Corporation
  • Coloplast A/S
  • Convatec Group PLC
  • Dentsply
  • Bactiguard
  • Hollister Incorporated
  • Pacific Hospital Supply Co. Ltd.
  • Rochester Medical Corporation
  • Fuqing Medical
  • Medsuyun
  • Songhang
  • Sanli
  • Chensheng Medical
  • Haiou Medical
  • CATHETRIX
  • World Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global And China Catheter Market, By Product Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Cardiovascular catheter
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Urology Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Intravenous Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Neurovascular Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Specialty Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

5. Global And China Catheter Market, By End User, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global And China Catheter Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2021-2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa
      • Rest of Africa

7. Company Profiles

  • Cordis (Cardinal Health)*
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • B. BRAUN
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teleflex Corporation
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • C. R. Bard, Inc.
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RIST Neurovascular, Inc.
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Edwards Lifesciences
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cook Medical Incorporated
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merit Medical
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biotronik
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BALT
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Osypka AG
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Japan Lifeline
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ACT
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lepu
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Microport
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SCW Medicath
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Coloplast A/S
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Convatec Group PLC
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dentsply
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bactiguard
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hollister Incorporated
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pacific Hospital Supply Co. Ltd.
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Rochester Medical Corporation
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fuqing Medical
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medsuyun
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Songhang
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sanli
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Chensheng Medical
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Haiou Medical
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CATHETRIX
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • World Medical
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact